id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-305560-ade9wqwk	Nestler, Matthew J.	Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center	2020-07-23		.txt	text/plain	1125	71	48	1 Many patients requiring hospitalization for COVID-19 present with symptoms mimicking community-acquired bacterial pneumonia prompting empiric antibiotic use. 2, 3 Antibiotic usage trends are starting to be published; a study by Velasco Arnaiz et al 4 showed increased pediatric inpatient azithromycin and ceftriaxone use in March and April of 2020 compared to the same months in 2019. We hypothesized that antibiotic days of therapy per 1,000 patient days (DOT per 1,000 PD) for key antimicrobials targeting pneumonia would be affected for April and May of 2020 when compared to the average DOT per 1,000 PD over the preceding year due to the impact of COVID-19 on our health system. The antibiotics ceftriaxone, azithromycin, levofloxacin, doxycycline, cefepime, piperacillin-tazobactam, meropenem, and vancomycin were chosen due to their common use for either communityacquired pneumonia (CAP) or hospital-acquired/ventilatorassociated pneumonia (HAP/VAP) coverage. Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center.	./cache/cord-305560-ade9wqwk.txt	./txt/cord-305560-ade9wqwk.txt